Completed
Neoadjuvant Pembrolizumab
NCT02818920
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
- Duke University Medical Center Durham, North Carolina, United States